Access cutting-edge adult congenital heart disease treatment through this clinical trial at a research site in Lebanon. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lebanon location
Preparing your pre-screening questions…
Access adult congenital heart disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adult congenital heart disease treatment provided free
Check if you qualify for this adult congenital heart disease clinical trial in Lebanon, NH
No-Cost Study Care
Local to Lebanon
Convenient for NH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study, entitled "Psychological trauma, post-traumatic stress disorder, and resilience in adults with congenital heart disease in a large population sample", is to evaluate for exposures during a lifetime with congenital heart disease that may be associated with higher likelihood of developing PTSD. Primary aim: \- Identify individual patient characteristics (medical, psychosocial, socioeconomic, etc.) that are associated with a diagnosis of PTSD. Secondary aims: * Calculate the prevalence of those meeting PTSD criteria in the ACHD population using the "gold standard" diagnostic clinician interview, while using the same data to validate a PTSD screening self-report survey in the ACHD population. * Determine the role of resilience in ACHD patients using a validated screening survey to assess its protective role toward PTSD. Hypotheses: * There are certain exposures (e.g. post-surgical pain, ICU delirium, bullying due to CHD) that are associated with a higher incidence and odds of meeting PTSD criteria. * "Gold standard" diagnostic interviews will most accurately estimate the prevalence of PTSD in ACHD which has been overestimated on prior screening-based studies, although the scope of the problem is still great. * Patients with a higher resilience score will show an association with a lower risk of PTSD.
Sponsor: Dartmouth-Hitchcock Medical Center
Yes, this clinical trial (NCT06952933) has an active research site in Lebanon, NH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for adult congenital heart disease treatment options in Lebanon, NH, this clinical trial (NCT06952933) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lebanon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adult congenital heart disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all adult congenital heart disease clinical trials near you to find additional studies recruiting in your area.
See all heart disease clinical trials recruiting in Lebanon — not just this study.
Browse Heart Disease Trials in Lebanon →